Jan Gheuens joined the Bill and Melinda Gates Foundation in 2007 as a Senior Program Officer for the Tuberculosis program. In this role, he focuses on the development of new TB diagnostics, vaccines and drugs.Dr. Gheuens came to the BMGF from Amgen, where he was Vice President, Global Development Operations, and R&D Japan. In this capacity, he enhanced Amgen's global clinical trial capability, added regional competencies in Eastern Europe, Latin America and Asia, and managed a team accountable for the execution of clinical trials in over 35 countries.Prior to his 6 years at Amgen, Dr. Gheuens spent 10 years at Johnson and Johnson. He took on various product development, clinical development and medical affairs roles of increasing responsibility at Janssen Research Foundation and Janssen Pharmaceutica US, culminating as Vice President Medical Affairs.Before joining the biopharmaceutical sector he was trained as a Neurologist in his native Belgium, did a postdoctoral fellowship in the NIH Intramural Program, was awarded a Ph.D. in Neuroimmunology, and served for 7 years on the faculty at the University Hospital of Antwerp.